Welcome
The Cardio-CARE at Medizincampus Davos, Switzerland, is funded by the Kühne Foundation. With 13 million Swiss Francs, it enables the largest research program to date for genome decoding in German-speaking regions. The main aims of our project are to
- better understand the genetic basic of cardiovascular diseases,
- improve its diagnosis, and
- identify drug targets.
This multidisciplinary project benefits from the intensive collaboration between the Kühne Foundation, the University Medical Center Zurich (USZ), and the University Medical Center Hamburg-Eppendorf (UKE).
“In future, diseases will be better avoided and cured if we help the medical profession to better understand the occurrence of disease in each individual.”
─ Prof. Dr. h.c. Klaus-Michael Kühne ─
Everything about Cardio-CARE
- Experts in pre-processing of large-scale high-throughput genome sequences.
- Experts in data analysis of high-throughput genome sequences.
- Long-standing experience in machine learning and artificial intelligence.
- Support planning, conduct and analysis of trials focusing on cardiovascular diseases and personalized medicine.
- Support planning, conduct and analysis of trials focusing on medical devices, such as telemonitoring.
- Perform friendly customer-oriented biostatistical and bioinformatical consulting.
News
Absence of Classical Cardiovascular Risk Factors Is Associated With More Than ten Extra Years of Life
Our most recent study published in the New England Journal of Medicine on March 30, 2025, reveals that absence of these risk factors at 50
Diagnostic accuracy of a machine learning algorithm using point-of-care high-sensitivity cardiac troponin I for rapid rule-out of myocardial infarction: a retrospectiv study
We are excited to share our latest research from Cardio-CARE, in collaboration with the University Heart and Vascular Center Hamburg at the University Medical Center
